Not yet independently audited

This page was written from verified sources but has not yet passed the independent citation audit. Treat its claims as provisional.

Bibliography — type 1 diabetes¶

Last curated: 2026-10-29

282 unique PubMed records. The 2026-10-22 sweep added 3 records, each cited from a wiki page. They were retrieved through live PubMed E-utilities on 2026-10-22 and checked against PubMed publication types and Crossref. None carried a retraction or expression-of-concern publication type, and Crossref showed no retraction update. Older entries retain their prior audit provenance; bibliography-only records are labeled explicitly. No new landmark note was warranted. NICE TA1176 has no PMID and is cited by URL in the wiki and guideline registry, not in this file. The 2026-10-29 sweep added 7 records: 6 cited from wiki pages and 1 bibliography-only (acmopatide). It also moved the Klemann HLH case from bibliography-only to cited, after its full text was read. All 7 additions and the Klemann record were checked against PubMed publication types (no Retracted Publication or Expression of Concern) and Crossref updated-by (empty).

Overview and burden¶

Livingstone SJ, et al. Estimated life expectancy in a Scottish cohort with type 1 diabetes, 2008-2010. JAMA. 2015;313:37-44. PMID 25562264 — tags: [overview-burden] — cited by: epidemiology-and-burden.md, overview.md
Raab J, et al. Capillary blood islet autoantibody screening for identifying pre-type 1 diabetes in the general population: design and initial results of the Fr1da study. BMJ Open. 2016. PMID 27194320 — tags: [overview-burden] — cited by: overview.md, screening-and-early-detection.md, staging-and-natural-history.md
Foster NC, et al. State of Type 1 Diabetes Management and Outcomes from the T1D Exchange in 2016-2018. Diabetes Technol Ther. 2019;21:66-72. PMID 30657336 — tags: [overview-burden] — cited by: epidemiology-and-burden.md, guidelines.md, insulin-therapy-and-technology.md, overview.md, psychosocial-and-behavioral.md
Ziegler AG, et al. Yield of a Public Health Screening of Children for Islet Autoantibodies in Bavaria, Germany. JAMA. 2020;323:339-351. PMID 31990315 — tags: [overview-burden] — cited by: epidemiology-and-burden.md, guidelines.md, overview.md, screening-and-early-detection.md, staging-and-natural-history.md
Zhang Y, et al. Fear of hypoglycemia in patients with type 1 and 2 diabetes: a systematic review. J Clin Nurs. 2020. PMID 33091198 — tags: [overview-burden] — cited by: epidemiology-and-burden.md, hypoglycemia.md, overview.md, patient-experience-and-advocacy.md
Gregory GA, et al. Global incidence, prevalence, and mortality of type 1 diabetes in 2021 with projection to 2040. Lancet Diabetes Endocrinol. 2022;10:741-760. PMID 36113507 — tags: [overview-burden] — cited by: epidemiology-and-burden.md, genetics-and-environmental-triggers.md, overview.md, patient-experience-and-advocacy.md, staging-and-natural-history.md
GBD 2021 Diabetes Collaborators. Global, regional, and national burden of diabetes from 1990 to 2021, with projections to 2050. Lancet. 2023;402:203-234. PMID 37356446 — tags: [overview-burden] — cited by: epidemiology-and-burden.md, overview.md
Embick R, et al. The impact of stigma on the management of type 1 diabetes: A systematic review. Diabet Med. 2024;41:e15299. PMID 38361327 — tags: [overview-burden] — cited by: epidemiology-and-burden.md, patient-experience-and-advocacy.md, psychosocial-and-behavioral.md
Yang Q, et al. Real-world glycaemic outcomes of automated insulin delivery in type 1 diabetes: A meta-analysis. Diabetes Obes Metab. 2024;26:3753-3763. PMID 38888056 — tags: [overview-burden] — cited by: beta-cell-replacement.md, clinical-trials-landscape.md, epidemiology-and-burden.md, insulin-therapy-and-technology.md
American Diabetes Association Professional Practice Committee. 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes-2026. Diabetes Care. 2026. PMID 41358893 — tags: [overview-burden] — cited by: guidelines.md, overview.md
American Diabetes Association Professional Practice Committee. Summary of Revisions: Standards of Care in Diabetes-2026. Diabetes Care. 2026. PMID 41358896 — tags: [overview-burden] — cited by: overview.md
American Diabetes Association Professional Practice Committee. 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes-2026. Diabetes Care. 2026. PMID 41358900 — tags: [overview-burden] — cited by: overview.md
Zhang T, et al. Worldwide prevalence of diabetic ketoacidosis at diagnosis of type 1 diabetes: A systematic review and meta-analysis. Prev Med. 2026;210:108625. PMID 42303108 — tags: [overview-burden] — cited by: epidemiology-and-burden.md, overview.md, red-flags-and-safety-concerns.md, screening-and-early-detection.md
Peprah Osei E, et al. Global prevalence and correlates of diabetes distress in type 1 diabetes: A systematic review and meta-analysis. Diabetes Res Clin Pract. 2026;239:113452. PMID 42486409 — tags: [overview-burden] — cited by: overview.md, patient-experience-and-advocacy.md, psychosocial-and-behavioral.md

Natural history and screening¶

Ziegler AG, et al. International consensus guidance for general population screening for islet autoantibodies to diagnose early-stage type 1 diabetes: a nominal group technique process. Diabetologia. 2026. PMID 42720753 — tags: [natural-history-and-screening, sweep-2026-10-15] — cited by: screening-and-early-detection.md, guidelines.md; OPEN-QUESTIONS.md; guidelines/REGISTRY.md
Metghalchi S, et al. Maternal antibody transfer confounds type 1 diabetes screening in infancy: results from the French TRAKR cohort. Diabetes Metab. 2026. PMID 42880695 — tags: [natural-history-and-screening, sweep-2026-10-22] — cited by: screening-and-early-detection.md
Burbelo PD, et al. Predictive autoantibodies before the diagnosis of type I diabetes in adults. PLoS One. 2026;21(10):e0352531. PMID 42879429 — tags: [natural-history-and-screening, sweep-2026-10-22] — cited by: staging-and-natural-history.md; OPEN-QUESTIONS.md
Berka B, et al. Population-Based Screening for Type 1 Diabetes in Czechia: Results From the First 1% of the Paediatric Population. Diabetes Obes Metab. 2026. PMID 42935169 — tags: [natural-history-and-screening, general-population-screening, sweep-2026-10-29] — cited by: screening-and-early-detection.md; OPEN-QUESTIONS.md — abstract only (full text not open in Europe PMC); interim counts

Mechanism, genetics, and biomarkers¶

Palmer JP, et al. C-peptide is the appropriate outcome measure for T1D trials. Diabetes. 2004;53:250-264. PMID 14693724 — tags: [mechanism-genetics-biomarkers] — cited by: biomarkers.md, disease-modifying-immunotherapy.md
Barrett JC, et al. GWAS identifies over 40 T1D loci. Nat Genet. 2009;41:703-707. PMID 19430480 — tags: [mechanism-genetics-biomarkers] — cited by: biomarkers.md
Noble JA, Erlich HA. Genetics of type 1 diabetes. Cold Spring Harb Perspect Med. 2012;2:a007732. PMID 22315720 — tags: [mechanism-genetics-biomarkers] — cited by: biomarkers.md
Gupta S. Immunotherapies in diabetes mellitus type 1. Med Clin North Am. 2012;96:621-634. PMID 22703858 — tags: [mechanism-genetics-biomarkers] — cited by: immunopathogenesis.md
Ziegler AG, et al. Seroconversion to multiple islet autoantibodies and progression. JAMA. 2013;309:2473-2479. PMID 23780460 — tags: [mechanism-genetics-biomarkers] — cited by: biomarkers.md, overview.md, screening-and-early-detection.md, staging-and-natural-history.md
Usmani-Brown S, et al. Analysis of β-cell death by droplet digital PCR. Endocrinology. 2014;155:3694-3698. PMID 25004096 — tags: [mechanism-genetics-biomarkers] — cited by: biomarkers.md
Tomlinson MJ, et al. Fine mapping at chromosome 16p13.13. Diabetes. 2014;63:4360-4368. PMID 25008175 — tags: [mechanism-genetics-biomarkers] — cited by: biomarkers.md
Insel RA, et al. Staging presymptomatic T1D. Diabetes Care. 2015;38:1964-1974. PMID 26404926 — tags: [mechanism-genetics-biomarkers] — cited by: biomarkers.md, guidelines.md, overview.md, screening-and-early-detection.md, staging-and-natural-history.md
Willcox A, et al. Histology of Type 1 Diabetes Pancreas. Methods Mol Biol. 2016;1433:105-117. PMID 26801316 — tags: [mechanism-genetics-biomarkers] — cited by: immunopathogenesis.md
Pugliese A, et al. Protective HLA haplotype in autoantibody-positive relatives. Diabetes. 2016;65:1109-1119. PMID 26822082 — tags: [mechanism-genetics-biomarkers] — cited by: biomarkers.md
Pugliese A. Insulitis in the pathogenesis of type 1 diabetes. Pediatr Diabetes. 2016;17 Suppl 22:31-36. PMID 27411434 — tags: [mechanism-genetics-biomarkers] — cited by: immunopathogenesis.md
Lönnrot M, et al. Respiratory infections are temporally associated with initiation of type 1 diabetes autoimmunity. Diabetologia. 2017;60:1931-1940. PMID 28770319 — tags: [mechanism-genetics-biomarkers] — cited by: genetics-and-environmental-triggers.md, immunopathogenesis.md, staging-and-natural-history.md
Allen DW, et al. Maternal virus infections in pregnancy and type 1 diabetes in their offspring. Rev Med Virol. 2018;28:e1974. PMID 29569297 — tags: [mechanism-genetics-biomarkers] — cited by: genetics-and-environmental-triggers.md
Shields BM, et al. C-Peptide Decline in T1D Has Two Phases. Diabetes Care. 2018;41:1486-1492. PMID 29880650 — tags: [mechanism-genetics-biomarkers] — cited by: biomarkers.md, immunopathogenesis.md, staging-and-natural-history.md
Ovalle F, et al. Verapamil and beta cell function in adults with recent-onset type 1 diabetes. Nat Med. 2018;24:1108-1112. PMID 29988125 — tags: [mechanism-genetics-biomarkers] — cited by: immunopathogenesis.md, overview.md
Rodriguez-Calvo T, et al. Pancreas Pathology During the Natural History of Type 1 Diabetes. Curr Diab Rep. 2018;18:124. PMID 30293191 — tags: [mechanism-genetics-biomarkers] — cited by: immunopathogenesis.md
Vatanen T, et al. The human gut microbiome in early-onset type 1 diabetes from the TEDDY study. Nature. 2018;562:589-594. PMID 30356183 — tags: [mechanism-genetics-biomarkers] — cited by: genetics-and-environmental-triggers.md
Stewart CJ, et al. Temporal development of the gut microbiome in early childhood from the TEDDY study. Nature. 2018;562:583-588. PMID 30356187 — tags: [mechanism-genetics-biomarkers] — cited by: genetics-and-environmental-triggers.md
Sharp SA, et al. Improved Type 1 Diabetes Genetic Risk Score. Diabetes Care. 2019;42:200-207. PMID 30655379 — tags: [mechanism-genetics-biomarkers] — cited by: biomarkers.md, epidemiology-and-burden.md, genetics-and-environmental-triggers.md, screening-and-early-detection.md
Lin A, et al. Low-Dose ATG/GCSF in Established Type 1 Diabetes: A Five-Year Follow-up Report. Diabetes. 2021;70:1123-1129. PMID 33632742 — tags: [mechanism-genetics-biomarkers] — cited by: disease-modifying-immunotherapy.md, immunopathogenesis.md
Weiss A, et al. Progression likelihood score. Diabetologia. 2022;65:2121-2131. PMID 36028774 — tags: [mechanism-genetics-biomarkers] — cited by: biomarkers.md, clinical-trials-landscape.md, overview.md, screening-and-early-detection.md, staging-and-natural-history.md
McVean J, et al. Effect of Tight Glycemic Control on Pancreatic Beta Cell Function in Newly Diagnosed Pediatric Type 1 Diabetes. JAMA. 2023;329:980-989. PMID 36826834 — tags: [mechanism-genetics-biomarkers] — cited by: clinical-trials-landscape.md, disease-modifying-immunotherapy.md, immunopathogenesis.md, insulin-therapy-and-technology.md, overview.md
Isaacs SR, et al. Enteroviruses and risk of islet autoimmunity or type 1 diabetes. Lancet Diabetes Endocrinol. 2023;11:578-592. PMID 37390839 — tags: [mechanism-genetics-biomarkers] — cited by: genetics-and-environmental-triggers.md, immunopathogenesis.md, overview.md
Atkinson MA, et al. The pathogenic “symphony” in type 1 diabetes. Cell Metab. 2023;35:1500-1518. PMID 37478842 — tags: [mechanism-genetics-biomarkers] — cited by: genetics-and-environmental-triggers.md, immunopathogenesis.md, staging-and-natural-history.md
Phillip M, et al. Monitoring IAb-Positive Pre-Stage 3 T1D. Diabetes Care. 2024;47:1276-1298. PMID 38912694 — tags: [mechanism-genetics-biomarkers] — cited by: biomarkers.md, guidelines.md, overview.md, patient-experience-and-advocacy.md, screening-and-early-detection.md, staging-and-natural-history.md
Bonifacio E, et al. Type 1 diabetes risk factors, risk prediction and presymptomatic detection. Diabetes Obes Metab. 2025;27 Suppl 6:28-39. PMID 40134221 — tags: [mechanism-genetics-biomarkers] — cited by: genetics-and-environmental-triggers.md
Evans-Molina C, et al. T1D presenting in adults. Diabetes Obes Metab. 2025. PMID 40230204 — tags: [mechanism-genetics-biomarkers] — cited by: biomarkers.md, epidemiology-and-burden.md, genetics-and-environmental-triggers.md, red-flags-and-safety-concerns.md, staging-and-natural-history.md
Hu J, et al. A type 1 diabetes genetic risk score discriminates between type 1 diabetes and type 2 diabetes in a Chinese population. Diabetologia. 2025;68:1969-1982. PMID 40569436 — tags: [mechanism-genetics-biomarkers] — cited by: biomarkers.md, genetics-and-environmental-triggers.md, screening-and-early-detection.md
Low ZY, et al. Vitamin supplementation and its effect on incident type 1 diabetes mellitus and islet autoimmunity: a systematic review and meta-analysis. Front Immunol. 2025;16:1505324. PMID 40270966 — tags: [environment, prevention, vitamin-d] — cited by: genetics-and-environmental-triggers.md
Zhang H, et al. Maternal Autoimmune Diseases During Pregnancy and Offspring Type 1 Diabetes. JAMA Pediatr. 2026. PMID 42931746 — tags: [genetics-environment, family-history, sweep-2026-10-29] — cited by: genetics-and-environmental-triggers.md — abstract only (full text not retrievable)

Insulin and technology¶

Luo J, et al. Human versus analogue insulin for children and young adults with type 1 diabetes in low-resource settings (HumAn-1): a multicentre, open-label, randomised controlled trial. Lancet Diabetes Endocrinol. 2026;14:727-739. PMID 42409045 — tags: [insulin-and-technology, sweep-2026-10-15] — cited by: none; bibliography only — HumAn-1, full text pending; regional comparator relevance
Wilkinson T, et al. Glycemic Outcomes During Outpatient Use of Automated Insulin Delivery Without Meal Announcement in Adults with Type 1 Diabetes: Results from the CLOSE IT Randomized Controlled Trial. Diabetes Technol Ther. 2026;28:941-950. PMID 41681122 — tags: [insulin-and-technology, sweep-2026-10-15] — cited by: none; bibliography only — CLOSE IT, full text pending
Beck RW, et al. Effect of Continuous Glucose Monitoring on Glycemic Control in Adults Using Insulin Injections. JAMA. 2017;317:371-378. PMID 28118453 — tags: [insulin-technology] — cited by: guidelines.md, insulin-therapy-and-technology.md
Oskarsson P, et al. Impact of flash glucose monitoring on hypoglycaemia in adults using injections. Diabetologia. 2018;61:539-550. PMID 29273897 — tags: [insulin-technology] — cited by: insulin-therapy-and-technology.md
Agarwal S, et al. Racial-Ethnic Disparities in Diabetes Technology Use Among Young Adults. Diabetes Technol Ther. 2021;23:306-313. PMID 33155826 — tags: [insulin-technology] — cited by: insulin-therapy-and-technology.md, patient-experience-and-advocacy.md, psychosocial-and-behavioral.md
Fantasia KL, et al. Racial Disparities in Diabetes Technology Use and Outcomes in a Safety-Net Hospital. J Diabetes Sci Technol. 2021;15:1010-1017. PMID 33719610 — tags: [insulin-technology] — cited by: insulin-therapy-and-technology.md, patient-experience-and-advocacy.md, psychosocial-and-behavioral.md
Ware J, et al. Randomized Trial of Closed-Loop Control in Very Young Children. N Engl J Med. 2022;386:209-219. PMID 35045227 — tags: [insulin-technology] — cited by: insulin-therapy-and-technology.md
Kruger D, et al. Multicenter Randomized Trial of the Insulin-Only Bionic Pancreas in Adults. Diabetes Technol Ther. 2022;24:697-711. PMID 36173236 — tags: [insulin-technology] — cited by: insulin-therapy-and-technology.md
Klein KR, et al. A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Acmopatide (CT-868), a Fully Biased GLP-1/GIP Receptor Agonist, in Adults With Type 1 Diabetes and Overweight or Obesity. Diabetes Care. 2026. PMID 42949535 — tags: [insulin-technology, adjunct-therapy, sweep-2026-10-29] — cited by: none; bibliography only — 16-week phase 2 (n=111; NCT06062069); abstract only; adjunct GLP-1/GIP therapy is not yet synthesized on the insulin page

Disease modification¶

Rosenzwajg M, et al. Efficacy and safety of low-dose IL-2 in people with newly diagnosed type 1 diabetes (DIABIL-2): a double-blind, multicentre, randomised, placebo-controlled, phase 2b trial. Lancet Diabetes Endocrinol. 2026. PMID 42822480 — tags: [disease-modification, sweep-2026-10-15] — cited by: none; bibliography only — DIABIL-2, full text pending
Samuelsson H, et al. Delayed time to stage 3 type 1 diabetes after GAD-alum treatment in HLA-DR3-DQ2-positive children: follow-up of the randomised placebo-controlled Diabetes Prevention - Immune Tolerance trial. Diabetologia. 2026. PMID 42806034 — tags: [disease-modification, sweep-2026-10-15] — cited by: disease-modifying-immunotherapy.md; OPEN-QUESTIONS.md
Herold KC, et al. Preserving beta cell function in children and adolescents with newly diagnosed stage 3 type 1 diabetes: per-protocol population analysis from the PROTECT randomised trial. Diabetologia. 2026. PMID 42720752 — tags: [disease-modification, sweep-2026-10-15] — cited by: disease-modifying-immunotherapy.md; OPEN-QUESTIONS.md; statistics/STATISTICS.md
Pescovitz MD, et al. Rituximab, B-lymphocyte depletion, and preservation of beta-cell function. N Engl J Med. 2009;361:2143-2152. PMID 19940299 — tags: [disease-modification] — cited by: disease-modifying-immunotherapy.md
Orban T, et al. Co-stimulation modulation with abatacept in recent-onset type 1 diabetes. Lancet. 2011;378:412-419. PMID 21719096 — tags: [disease-modification] — cited by: disease-modifying-immunotherapy.md
Haller MJ, et al. Low-Dose ATG Preserves β-Cell Function and Improves HbA1c. Diabetes Care. 2018;41:1917-1925. PMID 30012675 — tags: [disease-modification] — cited by: clinical-trials-landscape.md, disease-modifying-immunotherapy.md
Forlenza GP, et al. Effect of Verapamil on Pancreatic Beta Cell Function. JAMA. 2023;329:990-999. PMID 36826844 — tags: [disease-modification] — cited by: clinical-trials-landscape.md, disease-modifying-immunotherapy.md, immunopathogenesis.md, overview.md
Ramos EL, et al. Teplizumab and β-Cell Function in Newly Diagnosed Type 1 Diabetes. N Engl J Med. 2023;389:2151-2161. PMID 37861217 — tags: [disease-modification] — cited by: disease-modifying-immunotherapy.md, immunopathogenesis.md, overview.md
Piemonti L, et al. Induction of immune education in type 1 diabetes through controlled allogeneic islet rejection at onset: a monocentric open-label pilot study. EClinicalMedicine. 2025;90:103685. PMID 41438972 — tags: [disease-modification, tolerance] — cited by: disease-modifying-immunotherapy.md, immunopathogenesis.md

Cell replacement¶

Hering BJ, et al. Phase 3 Trial of Transplantation of Human Islets in T1D Complicated by Severe Hypoglycemia. Diabetes Care. 2016;39:1230-1240. PMID 27208344 — tags: [cell-replacement] — cited by: beta-cell-replacement.md, clinical-trials-landscape.md
Foster ED, et al. Improved Health-Related Quality of Life in a Phase 3 Islet Transplantation Trial. Diabetes Care. 2018;41:1001-1008. PMID 29563196 — tags: [cell-replacement] — cited by: beta-cell-replacement.md
Brown SA, et al. Six-Month Randomized, Multicenter Trial of Closed-Loop Control. N Engl J Med. 2019;381:1707-1717. PMID 31618560 — tags: [cell-replacement] — cited by: beta-cell-replacement.md, clinical-trials-landscape.md, complications.md, epidemiology-and-burden.md, guidelines.md, hypoglycemia.md, insulin-therapy-and-technology.md, overview.md
Ramzy A, et al. Implanted pluripotent stem-cell-derived pancreatic endoderm cells secrete glucose-responsive C-peptide. Cell Stem Cell. 2021;28:2047-2061.e5. PMID 34861146 — tags: [cell-replacement] — cited by: beta-cell-replacement.md
Reichman TW, et al. Stem Cell-Derived, Fully Differentiated Islets for Type 1 Diabetes. N Engl J Med. 2025;393:858-868. PMID 40544428 — tags: [cell-replacement] — cited by: beta-cell-replacement.md, clinical-trials-landscape.md, overview.md

Acute safety¶

Klemann C, Kordonouri O. Fulminant Secondary HLH Following EBV Reactivation in an Adult With Trisomy 21 After Teplizumab Treatment for Stage 2 Type 1 Diabetes. Diabetes Care. 2026;49:1790-1794. PMID 42520060 — tags: [acute-safety, teplizumab, sweep-2026-10-15, sweep-2026-10-29] — cited by: disease-modifying-immunotherapy.md; OPEN-QUESTIONS.md — single case; full text (PMC13594791) read 2026-10-29; causality unestablished per authors
Riddell MC, et al. Exercise management in type 1 diabetes. Lancet Diabetes Endocrinol. 2017;5:377-390. PMID 28126459 — tags: [acute-safety] — cited by: red-flags-and-safety-concerns.md
Rickels MR. Hypoglycemia-associated autonomic failure and therapeutic options. Ann N Y Acad Sci. 2019;1454:68-79. PMID 31389033 — tags: [acute-safety] — cited by: guidelines.md, hypoglycemia.md, red-flags-and-safety-concerns.md
Matsuhisa M, et al. Nasal glucagon for insulin-induced hypoglycaemia. Diabetes Obes Metab. 2020;22:1167-1175. PMID 32115879 — tags: [acute-safety] — cited by: hypoglycemia.md
Pieber TR, et al. Dasiglucagon for Severe Hypoglycemia. Diabetes Care. 2021;44:1361-1367. PMID 35239971 — tags: [acute-safety] — cited by: hypoglycemia.md, red-flags-and-safety-concerns.md
Amiel SA, et al. Hypoglycaemia Awareness Restoration Programme randomized trial. Nat Commun. 2022;13:2229. PMID 35484106 — tags: [acute-safety] — cited by: hypoglycemia.md
Ali N, et al. Fall in prevalence of impaired awareness of hypoglycaemia. Diabet Med. 2023. PMID 36645139 — tags: [acute-safety] — cited by: hypoglycemia.md, overview.md
Zammitt NN, et al. Predictors of impaired awareness and severe hypoglycaemia. Diabet Med. 2025. PMID 40386839 — tags: [acute-safety] — cited by: complications.md, hypoglycemia.md, overview.md, red-flags-and-safety-concerns.md

Complications¶

DCCT Research Group. Effect of intensive treatment on long-term complications. N Engl J Med. 1993;329:977-986. PMID 8366922 — tags: [complications] — cited by: complications.md, guidelines.md, insulin-therapy-and-technology.md, overview.md
Nathan DM, et al. Intensive diabetes treatment and cardiovascular disease. N Engl J Med. 2005;353:2643-2653. PMID 16371630 — tags: [complications] — cited by: complications.md
Cengiz E, et al. Severe hypoglycemia and DKA among youth in T1D Exchange. Pediatr Diabetes. 2013;14:447-454. PMID 23469984 — tags: [complications] — cited by: complications.md, hypoglycemia.md
DCCT/EDIC Study Research Group. Intensive Diabetes Treatment and Cardiovascular Outcomes: 30-Year Follow-up. Diabetes Care. 2016. PMID 26861924 — tags: [complications] — cited by: complications.md, overview.md
Rawshani A, et al. Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes. N Engl J Med. 2017. PMID 28402770 — tags: [complications] — cited by: complications.md, epidemiology-and-burden.md, overview.md
DCCT/EDIC Research Group, et al. Frequency of Evidence-Based Screening for Retinopathy. N Engl J Med. 2017;376:1507-1516. PMID 28423305 — tags: [complications] — cited by: complications.md
Rawshani A, et al. Excess mortality and cardiovascular disease by age at onset. Lancet. 2018;392:477-486. PMID 30129464 — tags: [complications] — cited by: complications.md, epidemiology-and-burden.md, overview.md
Heerspink HJL, et al. Finerenone in Type 1 Diabetes and Chronic Kidney Disease. N Engl J Med. 2026;394:947-957. PMID 41780000 — tags: [complications, kidney, FINE-ONE, sweep-2026-10-29] — cited by: complications.md, clinical-trials-landscape.md; OPEN-QUESTIONS.md — abstract only (full text closed); primary result corroborated in the open full text of PMID 42258447
Beernink JM, et al. Effect of Finerenone on Albuminuria in Type 1 Diabetes by Baseline HbA1c Level and Diabetes Duration: An Exploratory Analysis of the FINE-ONE Trial. Diabetes Care. 2026;49:1434-1441. PMID 42258447 — tags: [complications, kidney, FINE-ONE, sweep-2026-10-29] — cited by: complications.md; OPEN-QUESTIONS.md — full text (PMC13385502) read
Cherney DZI, et al. Acute eGFR Changes With Finerenone Examined in a Prespecified Analysis of FINE-ONE. Kidney Int Rep. 2026;11:107083. PMID 42927222 — tags: [complications, kidney, FINE-ONE, sweep-2026-10-29] — cited by: complications.md — full text (PMC13694952) read

Psychosocial and patient experience¶

Speight J, et al. 2026 EASD evidence-based clinical practice guideline for assessing and managing diabetes distress among adults with type 1 diabetes or type 2 diabetes. Diabetologia. 2026. PMID 42744915 — tags: [psychosocial-and-patient-experience, sweep-2026-10-15] — cited by: psychosocial-and-behavioral.md, guidelines.md; guidelines/REGISTRY.md
Whittemore R, et al. Psychological experience of parents of children with T1D. Diabetes Educ. 2012;38:562-579. PMID 22581804 — tags: [psychosocial-patient-experience] — cited by: patient-experience-and-advocacy.md, psychosocial-and-behavioral.md
Hanlan ME, et al. Eating Disorders and Disordered Eating in T1D. Curr Diab Rep. 2013. PMID 24022608 — tags: [psychosocial-patient-experience] — cited by: psychosocial-and-behavioral.md
Peterson CM, et al. Comprehensive risk model for disordered eating in youth with T1D. J Pediatr Psychol. 2015;40:385-390. PMID 25502449 — tags: [psychosocial-patient-experience] — cited by: psychosocial-and-behavioral.md
Garvey KC, et al. Health Care Transition in Young Adults With T1D. Diabetes Care. 2016;39:190-197. PMID 26681724 — tags: [psychosocial-patient-experience] — cited by: psychosocial-and-behavioral.md
Fisher L, et al. Diabetes distress in adults with T1D. J Diabetes Complications. 2016;30:1123-1128. PMID 27118163 — tags: [psychosocial-patient-experience] — cited by: psychosocial-and-behavioral.md
Campbell F, et al. Transition of care from paediatric to adult services. Cochrane Database Syst Rev. 2016;4:CD009794. PMID 27128768 — tags: [psychosocial-patient-experience] — cited by: psychosocial-and-behavioral.md
Pulungan AB, et al. Availability and access to pediatric diabetes care. Clin Pediatr Endocrinol. 2023;32:137-146. PMID 37362165 — tags: [psychosocial-patient-experience] — cited by: patient-experience-and-advocacy.md
Lakshman R, et al. Lived Experience of Fully Closed-Loop Insulin Delivery. Diabetes Technol Ther. 2024;26:211-221. PMID 38426909 — tags: [psychosocial-patient-experience] — cited by: patient-experience-and-advocacy.md, psychosocial-and-behavioral.md

Guidelines¶

de Beaufort C, et al. The transition of youth with diabetes from paediatric to adult diabetes care services: a consensus report of the joint working group of ISPAD, EASD and ADA. Horm Res Paediatr. 2026. PMID 42784528 — tags: [guidelines, sweep-2026-10-22] — cited by: guidelines.md, psychosocial-and-behavioral.md; OPEN-QUESTIONS.md; guidelines/REGISTRY.md
Gómez Gila AL, et al. Executive summary of the Integrated Clinical care pathway for the detection and management of preclinical stages of type 1 diabetes: SED-SEEN-SEEP consensus. An Pediatr (Engl Ed). 2026;105:504341. PMID 42760247 — tags: [guidelines, sweep-2026-10-15] — cited by: guidelines/REGISTRY.md; executive-summary catalog only
McGill JB, et al. American Association of Clinical Endocrinology Consensus Statement: Use of Diabetes Technology for Management of Adults with Diabetes. Endocr Pract. 2026. PMID 42709002 — tags: [guidelines, sweep-2026-10-15] — cited by: guidelines/REGISTRY.md; catalog only, recommendation synthesis deferred
Olsen MT, et al. An international position statement on practical approaches for inpatient continuous glucose monitoring, insulin pumps and automated insulin delivery systems in adults. Diabetologia. 2026. PMID 42771181 — tags: [guidelines, sweep-2026-10-15] — cited by: guidelines.md, insulin-therapy-and-technology.md; guidelines/REGISTRY.md
Holt RIG, et al. Correction: The management of type 1 diabetes in adults. The updated 2026 consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia. 2026. PMID 42814152 — tags: [guidelines, sweep-2026-10-15] — cited by: guidelines.md; guidelines/REGISTRY.md
Holt RIG, et al. The management of type 1 diabetes in adults. The updated 2026 consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia. 2026. PMID 42747450 — tags: [guidelines, sweep-2026-10-15] — cited by: guidelines.md, insulin-therapy-and-technology.md; guidelines/REGISTRY.md
Lindholm Olinder A, et al. ISPAD Clinical Practice Consensus Guidelines 2022: Diabetes education in children and adolescents. Pediatr Diabetes. 2022;23:1229-1242. PMID 36120721 — tags: [guidelines, education] — cited by: guidelines.md
Danne T, et al. Consensus on DKA Risk Management With SGLT Inhibitors. Diabetes Care. 2019;42:1147-1154. PMID 30728224 — tags: [guidelines] — cited by: guidelines.md, red-flags-and-safety-concerns.md
Battelino T, et al. Clinical Targets for CGM Data Interpretation. Diabetes Care. 2019;42:1593-1603. PMID 31177185 — tags: [guidelines] — cited by: guidelines.md, insulin-therapy-and-technology.md, overview.md
Glaser N, et al. ISPAD 2022: DKA and hyperglycemic hyperosmolar state. Pediatr Diabetes. 2022;23:835-856. PMID 36250645 — tags: [guidelines] — cited by: guidelines.md, red-flags-and-safety-concerns.md
de Wit M, et al. ISPAD 2022: Psychological care. Pediatr Diabetes. 2022;23:1373-1389. PMID 36464988 — tags: [guidelines] — cited by: guidelines.md
Adolfsson P, et al. ISPAD 2022: Exercise. Pediatr Diabetes. 2022;23:1341-1372. PMID 36537529 — tags: [guidelines] — cited by: guidelines.md, red-flags-and-safety-concerns.md
Bjornstad P, et al. ISPAD 2022: Microvascular and macrovascular complications. Pediatr Diabetes. 2022;23:1432-1450. PMID 36537531 — tags: [guidelines] — cited by: guidelines.md
Abraham MB, et al. ISPAD Clinical Practice Consensus Guidelines 2022: Assessment and management of hypoglycemia in children and adolescents with diabetes. Pediatr Diabetes. 2022;23:1322-1340. PMID 36537534 — tags: [guidelines, hypoglycemia] — cited by: guidelines.md
Haller MJ, et al. ISPAD 2024: Screening, Staging, and β-Cell Preservation. Horm Res Paediatr. 2024;97:529-545. PMID 39662065 — tags: [guidelines] — cited by: guidelines.md, staging-and-natural-history.md
de Bock M, et al. ISPAD 2024: Glycemic Targets. Horm Res Paediatr. 2024;97:546-554. PMID 39701064 — tags: [guidelines] — cited by: guidelines.md
ADA Professional Practice Committee. Diabetes Technology: Standards of Care in Diabetes—2026. Diabetes Care. 2026. PMID 41358889 — tags: [guidelines] — cited by: guidelines.md, overview.md

Clinical trials¶

TrialNet Oral Insulin Study Group. Oral Insulin Prevention Trial. JAMA. 2017;318:1891-1902. PMID 29164254 — tags: [clinical-trials] — cited by: clinical-trials-landscape.md, disease-modifying-immunotherapy.md
Herold KC, et al. Teplizumab in Relatives at Risk. N Engl J Med. 2019;381:603-613. PMID 31180194 — tags: [clinical-trials] — cited by: biomarkers.md, clinical-trials-landscape.md, disease-modifying-immunotherapy.md, immunopathogenesis.md, overview.md, screening-and-early-detection.md, staging-and-natural-history.md
Russell WE, et al. Abatacept for Stage-1 Progression. Diabetes Care. 2023;46:1005-1013. PMID 36920087 — tags: [clinical-trials] — cited by: biomarkers.md, clinical-trials-landscape.md, disease-modifying-immunotherapy.md, immunopathogenesis.md, staging-and-natural-history.md
Zeng B, et al. AID in Children and Adolescents. Diabetes Care. 2023. PMID 38011519 — tags: [clinical-trials] — cited by: clinical-trials-landscape.md, insulin-therapy-and-technology.md, overview.md
Di Molfetta S, et al. Hybrid Closed Loop Network Meta-analysis. Diabetes Metab Res Rev. 2024. PMID 39298688 — tags: [clinical-trials] — cited by: clinical-trials-landscape.md, guidelines.md, insulin-therapy-and-technology.md, overview.md
Canha D, et al. AID and diabetes distress. Diabet Med. 2025. PMID 39726162 — tags: [clinical-trials] — cited by: clinical-trials-landscape.md, hypoglycemia.md, overview.md, patient-experience-and-advocacy.md, psychosocial-and-behavioral.md
Anwar IJ, et al. The anti-CD40L monoclonal antibody AT-1501 promotes islet and kidney allograft survival and function in nonhuman primates. Sci Transl Med. 2023;15:eadf6376. PMID 37647390 — tags: [clinical-trials, cell-replacement, tegoprubart, preclinical, sweep-2026-10-29] — cited by: clinical-trials-landscape.md — nonhuman primate data only

2026-08-30 deepening additions¶

These records were added during the page-by-page deepening pass. The section is chronological and deduplicated by PMID; topical tags remain searchable through the citing-page field.

Wibell L, et al. Increased mortality in diabetes during the first 10 years. J Intern Med. 2001;249:263-270. PMID 11285046 — tags: [2026-deepening] — cited by: hypoglycemia.md
Hviid A, et al. Childhood vaccination and type 1 diabetes. N Engl J Med. 2004;350:1398-1404. PMID 15070789 — tags: [2026-deepening] — cited by: genetics-and-environmental-triggers.md
Barker JM, et al. Prediction of autoantibody positivity and progression to type 1 diabetes: DAISY. J Clin Endocrinol Metab. 2004;89:3896-3902. PMID 15292324 — tags: [2026-deepening] — cited by: screening-and-early-detection.md, staging-and-natural-history.md
Dagogo-Jack S. Hypoglycemia in type 1 diabetes mellitus: pathophysiology and prevention. Treat Endocrinol. 2004;3:91-103. PMID 15743105 — tags: [2026-deepening] — cited by: hypoglycemia.md
Genuth S. Insights from DCCT/EDIC on intensive glycemic treatment and complications. Endocr Pract. 2006;12 Suppl 1:34-41. PMID 16627378 — tags: [2026-deepening] — cited by: complications.md
Zipitis CS, Akobeng AK. Vitamin D supplementation in early childhood and risk of type 1 diabetes. Arch Dis Child. 2008;93:512-517. PMID 18339654 — tags: [2026-deepening] — cited by: genetics-and-environmental-triggers.md
Cure P, et al. Islet after kidney transplantation: metabolic control and quality of life. Transplantation. 2008;85:801-812. PMID 18360260 — tags: [2026-deepening] — cited by: beta-cell-replacement.md
Gangemi A, et al. Islet transplantation for brittle type 1 diabetes: the UIC protocol. Am J Transplant. 2008;8:1250-1261. PMID 18444920 — tags: [2026-deepening] — cited by: beta-cell-replacement.md
Bonifacio E, et al. Harmonization of glutamic acid decarboxylase and islet antigen-2 autoantibody assays. J Clin Endocrinol Metab. 2010;95:3360-3367. PMID 20444913 — tags: [2026-deepening] — cited by: screening-and-early-detection.md
Bruno G, et al. Age-period-cohort analysis of childhood diabetes in Italy. Diabetes. 2010;59:2281-2287. PMID 20566665 — tags: [2026-deepening] — cited by: epidemiology-and-burden.md
Posselt AM, et al. Islet transplantation using an efalizumab-based protocol. Am J Transplant. 2010;10:1870-1880. PMID 20659093 — tags: [2026-deepening] — cited by: beta-cell-replacement.md
Bingley PJ, et al. Measurement of islet cell antibodies in the Type 1 Diabetes Genetics Consortium. Clin Trials. 2010;7:S56-S64. PMID 20693189 — tags: [2026-deepening] — cited by: screening-and-early-detection.md
Campbell LK, et al. Neurocognition and recurrent driving mishaps in T1D. Int J Diabetes Mellit. 2010;2:73-77. PMID 21127720 — tags: [2026-deepening] — cited by: red-flags-and-safety-concerns.md
Berhan Y, et al. Thirty years of nationwide childhood type 1 diabetes incidence in Sweden. Diabetes. 2011;60:577-581. PMID 21270269 — tags: [2026-deepening] — cited by: epidemiology-and-burden.md
Yeung WC, et al. Enterovirus infection and type 1 diabetes mellitus: systematic review and meta-analysis. BMJ. 2011;342:d35. PMID 21292721 — tags: [2026-deepening] — cited by: genetics-and-environmental-triggers.md
de Boer IH, et al. Long-term renal outcomes after microalbuminuria in DCCT/EDIC. Arch Intern Med. 2011;171:412-420. PMID 21403038 — tags: [2026-deepening] — cited by: complications.md
Yu L, et al. Rituximab selectively suppresses specific islet antibodies. Diabetes. 2011;60:2560-2565. PMID 21831969 — tags: [2026-deepening] — cited by: disease-modifying-immunotherapy.md
Simpson M, et al. No association of vitamin D intake or 25-hydroxyvitamin D levels with islet autoimmunity and type 1 diabetes. Diabetologia. 2011;54:2779-2788. PMID 21858504 — tags: [2026-deepening] — cited by: genetics-and-environmental-triggers.md
Barton FB, et al. Improvement in outcomes of clinical islet transplantation: 1999-2010. Diabetes Care. 2012;35:1436-1445. PMID 22723582 — tags: [2026-deepening] — cited by: beta-cell-replacement.md, clinical-trials-landscape.md
Takita M, et al. Adverse events in clinical islet transplantation. Cell Transplant. 2012;21:547-551. PMID 22793063 — tags: [2026-deepening] — cited by: beta-cell-replacement.md
Shapiro AM. Islet transplantation in type 1 diabetes: long-term outcome. Rev Diabet Stud. 2012;9:385-406. PMID 23804275 — tags: [2026-deepening] — cited by: beta-cell-replacement.md
Fisher MM, et al. Detection of islet β-cell death in vivo by multiplex PCR of differentially methylated DNA. Endocrinology. 2013;154:3476-3481. PMID 23825129 — tags: [2026-deepening] — cited by: biomarkers.md
Frederiksen BN, et al. Vitamin D metabolism gene polymorphisms, islet autoimmunity, and T1D progression. J Clin Endocrinol Metab. 2013;98:E1845-E1851. PMID 23979957 — tags: [2026-deepening] — cited by: genetics-and-environmental-triggers.md
Shun CB, et al. Thyroid autoimmunity in Type 1 diabetes: systematic review and meta-analysis. Diabet Med. 2014;31:126-135. PMID 24103027 — tags: [2026-deepening] — cited by: complications.md
Leelarathna L, et al. Restoration of self-awareness of hypoglycemia: HypoCOMPaSS clamp substudy. Diabetes Care. 2013;36:4063-4070. PMID 24130355 — tags: [2026-deepening] — cited by: hypoglycemia.md
Little SA, et al. Recovery of hypoglycemia awareness: HypoCOMPaSS randomized trial. Diabetes Care. 2014;37:2114-2122. PMID 24854041 — tags: [2026-deepening] — cited by: hypoglycemia.md
de Boer IH, et al. Renal outcomes in patients with type 1 diabetes and macroalbuminuria. J Am Soc Nephrol. 2014;25:2342-2350. PMID 24925722 — tags: [2026-deepening] — cited by: complications.md
In't Veld P. Insulitis in human type 1 diabetes: a comparison between patients and animal models. Semin Immunopathol. 2014;36:569-579. PMID 25005747 — tags: [2026-deepening] — cited by: immunopathogenesis.md
Bruni A, et al. Islet cell transplantation: recent advances and future challenges. Diabetes Metab Syndr Obes. 2014;7:211-223. PMID 25018643 — tags: [2026-deepening] — cited by: beta-cell-replacement.md
Willi SM, et al. Racial-ethnic disparities in management and outcomes among children with type 1 diabetes. Pediatrics. 2015;135:424-434. PMID 25687140 — tags: [2026-deepening] — cited by: complications.md, epidemiology-and-burden.md, overview.md
Giannopoulou EZ, et al. Islet autoantibody phenotypes and incidence in children at increased risk. Diabetologia. 2015;58:2317-2323. PMID 26138334 — tags: [2026-deepening] — cited by: biomarkers.md
Uusitalo U, et al. Association of Early Exposure of Probiotics and Islet Autoimmunity in the TEDDY Study. JAMA Pediatr. 2016;170:20-28. PMID 26552054 — tags: [2026-deepening] — cited by: genetics-and-environmental-triggers.md
Soni A, et al. Management of children with T1D during illness: national survey. Postgrad Med J. 2016;92:447-449. PMID 26903663 — tags: [2026-deepening] — cited by: red-flags-and-safety-concerns.md
Peters AL, et al. DKA with canagliflozin in patients with T1D. Diabetes Care. 2016;39:532-538. PMID 26989182 — tags: [2026-deepening] — cited by: red-flags-and-safety-concerns.md
Ehlers MR. Strategies for clinical trials in type 1 diabetes. J Autoimmun. 2016;71:88-96. PMID 27068279 — tags: [2026-deepening] — cited by: disease-modifying-immunotherapy.md
Pinckney A, et al. Hypoglycemia, variability, and C-Peptide after alefacept in T1DAL. Clin Ther. 2016;38:1327-1339. PMID 27209482 — tags: [2026-deepening] — cited by: disease-modifying-immunotherapy.md
Gibb FW, et al. Risk of death following admission with diabetic ketoacidosis. Diabetologia. 2016;59:2082-2087. PMID 27397023 — tags: [2026-deepening] — cited by: complications.md, red-flags-and-safety-concerns.md
Mirmira RG, et al. Biomarkers of β-Cell Stress and Death in Type 1 Diabetes. Curr Diab Rep. 2016;16:95. PMID 27541297 — tags: [2026-deepening] — cited by: biomarkers.md, disease-modifying-immunotherapy.md
Reutrakul S, et al. Sleep characteristics in T1D: systematic review and meta-analysis. Sleep Med. 2016. PMID 27692274 — tags: [2026-deepening] — cited by: patient-experience-and-advocacy.md, psychosocial-and-behavioral.md
Hendrieckx C, et al. Severe hypoglycemia, impaired awareness, and self-monitoring in adults. J Diabetes Complications. 2017;31:577-582. PMID 27993524 — tags: [2026-deepening] — cited by: hypoglycemia.md
Frohnert BI, et al. Late-onset islet autoimmunity in childhood: DAISY. Diabetologia. 2017;60:998-1006. PMID 28314946 — tags: [2026-deepening] — cited by: screening-and-early-detection.md, staging-and-natural-history.md
Bone RN, Evans-Molina C. Combination Immunotherapy for Type 1 Diabetes. Curr Diab Rep. 2017;17:50. PMID 28534310 — tags: [2026-deepening] — cited by: disease-modifying-immunotherapy.md
McNeilly AD, McCrimmon RJ. Impaired hypoglycaemia awareness in type 1 diabetes: lessons from the lab. Diabetologia. 2018;61:743-750. PMID 29417183 — tags: [2026-deepening] — cited by: hypoglycemia.md
Little SA, et al. Sustained Reduction in Severe Hypoglycemia: Two-Year HypoCOMPaSS Follow-up. Diabetes Care. 2018;41:1600-1607. PMID 29661916 — tags: [2026-deepening] — cited by: hypoglycemia.md
Lablanche S, et al. Islet transplantation versus insulin therapy: TRIMECO randomized trial. Lancet Diabetes Endocrinol. 2018;6:527-537. PMID 29776895 — tags: [2026-deepening] — cited by: beta-cell-replacement.md, clinical-trials-landscape.md
Kuppermann N, et al. Clinical trial of fluid infusion rates for pediatric DKA. N Engl J Med. 2018;378:2275-2287. PMID 29897851 — tags: [2026-deepening] — cited by: red-flags-and-safety-concerns.md
Linsley PS, et al. Elevated T cell levels predict poor response following rituximab. Genes Immun. 2019;20:293-307. PMID 29925930 — tags: [2026-deepening] — cited by: disease-modifying-immunotherapy.md
Farrington C, et al. Women's Experiences of Day-and-Night Closed-Loop Insulin Delivery During Type 1 Diabetes Pregnancy. J Diabetes Sci Technol. 2018;12:1125-1131. PMID 30288999 — tags: [2026-deepening] — cited by: patient-experience-and-advocacy.md
Senior PA, Pettus JH. Stem cell therapies for Type 1 diabetes: roadmap for clinical trials. Diabet Med. 2019;36:297-307. PMID 30362170 — tags: [2026-deepening] — cited by: beta-cell-replacement.md
Nederstigt C, et al. Associated auto-immune disease in type 1 diabetes: systematic review and meta-analysis. Eur J Endocrinol. 2019;180:135-144. PMID 30508413 — tags: [2026-deepening] — cited by: complications.md
Perdigoto AL, et al. Treatment of type 1 diabetes with teplizumab: follow-up after 7 years. Diabetologia. 2019;62:655-664. PMID 30569273 — tags: [2026-deepening] — cited by: biomarkers.md, clinical-trials-landscape.md, disease-modifying-immunotherapy.md
Muñoz-Velandia O, et al. Patient values and preferences regarding pumps and artificial pancreas. Diabetes Technol Ther. 2019;21:183-200. PMID 30839227 — tags: [2026-deepening] — cited by: patient-experience-and-advocacy.md
Musso G, et al. Sotagliflozin in T1D: meta-analysis of randomized trials. BMJ. 2019;365:l1328. PMID 30967375 — tags: [2026-deepening] — cited by: red-flags-and-safety-concerns.md
Haller MJ, et al. Low-Dose ATG: Two-Year Clinical Trial Data. Diabetes. 2019;68:1267-1276. PMID 30967424 — tags: [2026-deepening] — cited by: clinical-trials-landscape.md, disease-modifying-immunotherapy.md
Lu J, et al. SGLT inhibitors added to insulin in T1D: meta-analysis of RCTs. Diabetes Metab Res Rev. 2019;35:e3169. PMID 30974510 — tags: [2026-deepening] — cited by: red-flags-and-safety-concerns.md
Purcell AW, et al. The Evolving Landscape of Autoantigen Discovery and Characterization in Type 1 Diabetes. Diabetes. 2019;68:879-886. PMID 31010879 — tags: [2026-deepening] — cited by: immunopathogenesis.md
Zaharieva DP, et al. CGM Lag Time During Aerobic Exercise in Adults with Type 1 Diabetes. Diabetes Technol Ther. 2019;21:313-321. PMID 31059282 — tags: [2026-deepening] — cited by: hypoglycemia.md, insulin-therapy-and-technology.md
Peters L, et al. Islet-immune interactions in type 1 diabetes: the nexus of beta-cell destruction. Clin Exp Immunol. 2019;198:326-340. PMID 31309537 — tags: [2026-deepening] — cited by: immunopathogenesis.md
Flatt AJS, et al. Predictors of Recurrent Severe Hypoglycemia During HypoCOMPaSS. Diabetes Care. 2020;43:44-52. PMID 31484666 — tags: [2026-deepening] — cited by: hypoglycemia.md
Vantyghem MC, et al. Ten-Year Outcome of Islet Alone or Islet After Kidney Transplantation. Diabetes Care. 2019;42:2042-2049. PMID 31615852 — tags: [2026-deepening] — cited by: beta-cell-replacement.md, clinical-trials-landscape.md
Monnier L, et al. Glycemic variability and mean glucose as predictors of hypoglycemia. Diabetes Care. 2020;43:821-827. PMID 31988062 — tags: [2026-deepening] — cited by: red-flags-and-safety-concerns.md
Pozzilli P, et al. Albiglutide Versus Placebo in Newly Diagnosed Type 1 Diabetes. J Clin Endocrinol Metab. 2020;105. PMID 32219329 — tags: [2026-deepening] — cited by: disease-modifying-immunotherapy.md
McQueen RB, et al. Cost and Cost-effectiveness of Large-scale Screening for Type 1 Diabetes in Colorado. Diabetes Care. 2020;43:1496-1503. PMID 32327420 — tags: [2026-deepening] — cited by: screening-and-early-detection.md
Harrison JW, et al. Type 1 diabetes genetic risk score is discriminative of diabetes in non-Europeans. Sci Rep. 2020;10:9450. PMID 32528078 — tags: [2026-deepening] — cited by: genetics-and-environmental-triggers.md, overview.md
Winkley K, et al. Psychological interventions to improve self-management of diabetes. Health Technol Assess. 2020;24:1-232. PMID 32568666 — tags: [2026-deepening] — cited by: psychosocial-and-behavioral.md
Liew AY, et al. Pre-transplant psychosocial burden in an integrated national islet transplant program. Islets. 2020;12:21-31. PMID 32815765 — tags: [2026-deepening] — cited by: beta-cell-replacement.md, patient-experience-and-advocacy.md
Moser O, et al. CGM-based glucose management for exercise in T1D. Diabetologia. 2020;63:2501-2520. PMID 33047169 — tags: [2026-deepening] — cited by: red-flags-and-safety-concerns.md
Faulkner CL, et al. The virome in early life and childhood and development of islet autoimmunity and type 1 diabetes. Rev Med Virol. 2021;31:1-14. PMID 33378601 — tags: [2026-deepening] — cited by: genetics-and-environmental-triggers.md
Gubitosi-Klug RA, et al. Residual β cell function in long-term type 1 diabetes associates with reduced incidence of hypoglycemia. J Clin Invest. 2021;131. PMID 33529168 — tags: [2026-deepening] — cited by: biomarkers.md, clinical-trials-landscape.md, complications.md, disease-modifying-immunotherapy.md, hypoglycemia.md, red-flags-and-safety-concerns.md
Warren M, et al. Improved postprandial glucose control with ultra rapid lispro versus lispro in pump therapy. Diabetes Obes Metab. 2021;23:1552-1561. PMID 33687783 — tags: [2026-deepening] — cited by: insulin-therapy-and-technology.md
de Klerk E, Hebrok M. Stem Cell-Based Clinical Trials for Diabetes Mellitus. Front Endocrinol. 2021;12:631463. PMID 33716982 — tags: [2026-deepening] — cited by: beta-cell-replacement.md
Chatwin H, et al. The impact of hypoglycaemia on quality of life in adults with type 1 diabetes. Diabetes Res Clin Pract. 2021;174:108752. PMID 33722700 — tags: [2026-deepening] — cited by: hypoglycemia.md
So M, et al. Advances in Type 1 Diabetes Prediction Using Islet Autoantibodies: Beyond a Simple Count. Endocr Rev. 2021;42:584-604. PMID 33881515 — tags: [2026-deepening] — cited by: biomarkers.md
Hall R, et al. Risk factors associated with insulin omission for weight loss in T1D. Clin Child Psychol Psychiatry. 2021;26:606-616. PMID 34121470 — tags: [2026-deepening] — cited by: psychosocial-and-behavioral.md
Inns T, et al. Paediatric rotavirus vaccination, coeliac disease and type 1 diabetes in children. BMC Med. 2021;19:147. PMID 34183004 — tags: [2026-deepening] — cited by: genetics-and-environmental-triggers.md
Krischer JP, et al. Characteristics of children diagnosed with type 1 diabetes before vs after 6 years of age in the TEDDY cohort study. Diabetologia. 2021;64:2247-2257. PMID 34291312 — tags: [2026-deepening] — cited by: overview.md
Harjutsalo V, et al. Long-term population-based trends in cardiovascular disease in type 1 diabetes. Lancet Diabetes Endocrinol. 2021;9:575-585. PMID 34303414 — tags: [2026-deepening] — cited by: complications.md, epidemiology-and-burden.md
Beran M, et al. The bidirectional longitudinal association between depressive symptoms and HbA1c: a systematic review and meta-analysis. Diabet Med. 2022;39:e14671. PMID 34407250 — tags: [2026-deepening] — cited by: psychosocial-and-behavioral.md
Abraham MB, et al. Hybrid closed loop and glycemic and psychosocial outcomes in youth. JAMA Pediatr. 2021;175:1227-1235. PMID 34633418 — tags: [2026-deepening] — cited by: psychosocial-and-behavioral.md
Leslie RD, et al. Adult-Onset Type 1 Diabetes: Current Understanding and Challenges. Diabetes Care. 2021;44:2449-2456. PMID 34670785 — tags: [2026-deepening] — cited by: epidemiology-and-burden.md, overview.md
Ng K, et al. Islet Autoantibody Type-Specific Titer Thresholds Improve Risk Stratification. Diabetes Care. 2022;45:160-168. PMID 34758977 — tags: [2026-deepening] — cited by: biomarkers.md, screening-and-early-detection.md, staging-and-natural-history.md
Manuwald U, et al. Trends in incidence and prevalence of type 1 diabetes in Saxony. PLoS One. 2021;16:e0262171. PMID 34972197 — tags: [2026-deepening] — cited by: epidemiology-and-burden.md
Boyko EJ, et al. Risk of Foot Ulcer and Lower-Extremity Amputation in DCCT/EDIC. Diabetes Care. 2022;45:357-364. PMID 35007329 — tags: [2026-deepening] — cited by: complications.md
Shapiro AMJ, et al. Insulin expression and C-peptide after stem-cell-derived pancreatic endoderm implantation. Cell Rep Med. 2021;2:100466. PMID 35028608 — tags: [2026-deepening] — cited by: beta-cell-replacement.md
Jacobsen LM, et al. Heterogeneity of DKA Incidence in Children Diagnosed in TEDDY. Diabetes Care. 2022;45:624-633. PMID 35043162 — tags: [2026-deepening] — cited by: screening-and-early-detection.md, staging-and-natural-history.md
Teo E, et al. Effectiveness of continuous glucose monitoring in type 1 diabetes. Diabetologia. 2022;65:604-619. PMID 35141761 — tags: [2026-deepening] — cited by: clinical-trials-landscape.md, insulin-therapy-and-technology.md
Fasolino M, et al. Single-cell multi-omics analysis of human pancreatic islets in type 1 diabetes. Nat Metab. 2022;4:284-299. PMID 35228745 — tags: [2026-deepening] — cited by: beta-cell-replacement.md, immunopathogenesis.md
Oram RA, et al. Utility of Diabetes Type-Specific Genetic Risk Scores for Classification Among Multiethnic Youth. Diabetes Care. 2022;45:1124-1131. PMID 35312757 — tags: [2026-deepening] — cited by: genetics-and-environmental-triggers.md
Harding JL, et al. The Incidence of Adult-Onset Type 1 Diabetes: A Systematic Review From 32 Countries and Regions. Diabetes Care. 2022;45:994-1006. PMID 35349653 — tags: [2026-deepening] — cited by: epidemiology-and-burden.md
Efthymiadis A, et al. The effectiveness of psychological interventions on mental health and quality of life in people living with type 1 diabetes: a systematic review and meta-analysis. Diabetol Int. 2022;13:513-521. PMID 35693990 — tags: [2026-deepening] — cited by: psychosocial-and-behavioral.md
Laine AP, et al. Non-HLA polymorphisms in T1D: phase- and endotype-specific effects. Front Immunol. 2022;13:909020. PMID 35812428 — tags: [2026-deepening] — cited by: genetics-and-environmental-triggers.md
Dhanasekaran M, et al. DKA in pregnancy: risk factors, presentation, and outcomes. J Clin Endocrinol Metab. 2022;107:3137-3143. PMID 35917830 — tags: [2026-deepening] — cited by: red-flags-and-safety-concerns.md
Choudhary P, et al. Advanced hybrid closed loop versus conventional treatment in adults with type 1 diabetes. Lancet Diabetes Endocrinol. 2022;10:720-731. PMID 36058207 — tags: [2026-deepening] — cited by: insulin-therapy-and-technology.md
Krischer JP, et al. Predictors of the Initiation of Islet Autoimmunity and Progression. Diabetes Care. 2022;45:2271-2281. PMID 36150053 — tags: [2026-deepening] — cited by: genetics-and-environmental-triggers.md, screening-and-early-detection.md, staging-and-natural-history.md
Sims EK, et al. Persistence of β-Cell Responsiveness for Over Two Years in Autoantibody-Positive Children. Diabetes Care. 2022;45:2982-2990. PMID 36326757 — tags: [2026-deepening] — cited by: biomarkers.md
Annan SF, et al. ISPAD 2022: Nutritional management in children and adolescents. Pediatr Diabetes. 2022;23:1297-1321. PMID 36468223 — tags: [2026-deepening] — cited by: guidelines.md
Deeb A, et al. ISPAD 2022: Ramadan and other religious fasting by young people with diabetes. Pediatr Diabetes. 2022;23:1512-1528. PMID 36537522 — tags: [2026-deepening] — cited by: guidelines.md
Tauschmann M, et al. ISPAD 2022: Diabetes technologies: Glucose monitoring. Pediatr Diabetes. 2022;23:1390-1405. PMID 36537528 — tags: [2026-deepening] — cited by: guidelines.md
Cengiz E, et al. ISPAD 2022: Insulin treatment in children and adolescents. Pediatr Diabetes. 2022;23:1277-1296. PMID 36537533 — tags: [2026-deepening] — cited by: guidelines.md
Ghalwash M, et al. Islet autoantibody screening in at-risk adolescents to predict type 1 diabetes. Lancet Child Adolesc Health. 2023;7:261-268. PMID 36681087 — tags: [2026-deepening] — cited by: screening-and-early-detection.md, staging-and-natural-history.md
Wadwa RP, et al. Trial of Hybrid Closed-Loop Control in Young Children. N Engl J Med. 2023;388:991-1001. PMID 36920756 — tags: [2026-deepening] — cited by: clinical-trials-landscape.md, insulin-therapy-and-technology.md
Thewjitcharoen Y, et al. Misdiagnosed adult-onset T1D identified by C-peptide testing. Heliyon. 2023;9:e14262. PMID 36923852 — tags: [2026-deepening] — cited by: red-flags-and-safety-concerns.md
Santos SS, et al. Increased risk of death following recurrent ketoacidosis admissions. Diabetol Metab Syndr. 2023;15:85. PMID 37106409 — tags: [2026-deepening] — cited by: complications.md, red-flags-and-safety-concerns.md
Hogrebe NJ, et al. Developments in stem cell-derived islet replacement therapy. Cell Stem Cell. 2023;30:530-548. PMID 37146579 — tags: [2026-deepening] — cited by: beta-cell-replacement.md
Lok CW, et al. Diabetes eating problem screening and prevalence in Chinese T1D. BMC Psychiatry. 2023;23:382. PMID 37259043 — tags: [2026-deepening] — cited by: psychosocial-and-behavioral.md
Wisel SA, et al. Calcineurin-Sparing Islet and Pancreas Transplantation. Transpl Int. 2023;36:11367. PMID 37359825 — tags: [2026-deepening] — cited by: beta-cell-replacement.md
Luckett AM, et al. Utility of genetic risk scores in type 1 diabetes. Diabetologia. 2023;66:1589-1600. PMID 37439792 — tags: [2026-deepening] — cited by: genetics-and-environmental-triggers.md
Ylescupidez A, et al. OGTT Metrics Surpass CGM Data for T1D Prediction in Multiple-Autoantibody-Positive Individuals. J Clin Endocrinol Metab. 2024;109:57-67. PMID 37572381 — tags: [2026-deepening] — cited by: biomarkers.md
Talbo MK, et al. Effect of diabetes technologies on fear of hypoglycaemia. EClinicalMedicine. 2023;62:102119. PMID 37593226 — tags: [2026-deepening] — cited by: hypoglycemia.md
O'Donnell HK, et al. Anxiety and Risk Perception in Parents of Children Identified by Population Screening as High Risk for Type 1 Diabetes. Diabetes Care. 2023;46:2155-2161. PMID 37673098 — tags: [2026-deepening] — cited by: patient-experience-and-advocacy.md, screening-and-early-detection.md
Godoi A, et al. Glucose control and psychosocial outcomes with automated insulin delivery for 12 to 96 weeks. Diabetol Metab Syndr. 2023;15:190. PMID 37759290 — tags: [2026-deepening] — cited by: insulin-therapy-and-technology.md
Lee TTM, et al. Automated insulin delivery in pregnancy complicated by T1D. N Engl J Med. 2023;389:1566-1578. PMID 37796241 — tags: [2026-deepening] — cited by: red-flags-and-safety-concerns.md
Xie S, et al. Health state utility values for children and adolescents with type 1 diabetes. Diabet Med. 2024;41:e15251. PMID 37915225 — tags: [2026-deepening] — cited by: complications.md, epidemiology-and-burden.md
Aiello EM, et al. Ketone-based alert system for insulin-pump failures. J Diabetes Sci Technol. 2025;19:683-691. PMID 37946403 — tags: [2026-deepening] — cited by: red-flags-and-safety-concerns.md
Singh M, et al. Autoimmune diseases and adverse pregnancy outcomes: an umbrella review. Lancet. 2023;402 Suppl 1:S84. PMID 37997130 — tags: [2026-deepening] — cited by: complications.md
Schipp J, et al. Psychosocial Outcomes Among Users and Nonusers of Open-Source Automated Insulin Delivery Systems. J Med Internet Res. 2023;25:e44002. PMID 38096018 — tags: [2026-deepening] — cited by: patient-experience-and-advocacy.md, psychosocial-and-behavioral.md
Knebel UE, et al. Disrupted RNA editing in beta cells mimics early-stage type 1 diabetes. Cell Metab. 2024;36:48-61.e6. PMID 38128529 — tags: [2026-deepening] — cited by: immunopathogenesis.md
Mattila M, et al. Fruit, berry, and vegetable consumption and risk of islet autoimmunity and T1D. Am J Clin Nutr. 2024;119:537-545. PMID 38142920 — tags: [2026-deepening] — cited by: genetics-and-environmental-triggers.md
Núñez-Baila MÁ, et al. Lifestyle in emerging adults with T1D: qualitative systematic review. Healthcare (Basel). 2024;12. PMID 38338194 — tags: [2026-deepening] — cited by: psychosocial-and-behavioral.md
Guo M, et al. SIGLEC-1-positive interferon-signature monocytes in recent-onset T1D. Diabetologia. 2024;67:623-640. PMID 38349399 — tags: [2026-deepening] — cited by: immunopathogenesis.md
Coomans de Brachène A, et al. Interferons are key cytokines acting on pancreatic islets in type 1 diabetes. Diabetologia. 2024;67:908-927. PMID 38409439 — tags: [2026-deepening] — cited by: immunopathogenesis.md
Honardoost MA, et al. Immune dysregulation and molecular subtypes revealed by single-cell RNA-seq in T1D. Genome Med. 2024;16:45. PMID 38539228 — tags: [2026-deepening] — cited by: immunopathogenesis.md
Howard KR, et al. Parent, child, and adolescent lived experience using the insulin-only iLet Bionic Pancreas. J Pediatr Psychol. 2024;49:413-420. PMID 38591792 — tags: [2026-deepening] — cited by: patient-experience-and-advocacy.md
Montaser E, et al. Novel Detection and Progression Markers for Diabetes Based on CGM Data Dynamics. J Clin Endocrinol Metab. 2025;110:254-262. PMID 38820084 — tags: [2026-deepening] — cited by: biomarkers.md
Aanstoot HJ, et al. Cohort profile: Biomarkers of heterogeneity in type 1 diabetes. BMJ Open. 2024;14:e082453. PMID 38904129 — tags: [2026-deepening] — cited by: biomarkers.md
Bell MJ, Neff OT. Exploring the intersection of income and race in people with Type 1 diabetes. Sociol Health Illn. 2024;46:1792-1807. PMID 38965795 — tags: [2026-deepening] — cited by: epidemiology-and-burden.md
Yi-Frazier JP, et al. Promoting resilience in adolescents with T1D: randomized clinical trial. JAMA Netw Open. 2024;7:e2428287. PMID 39158914 — tags: [2026-deepening] — cited by: psychosocial-and-behavioral.md
Garza KP, et al. Adult's Lived Experience Using the Insulin-Only Bionic Pancreas. J Diabetes Sci Technol. 2025;19:11-17. PMID 39212346 — tags: [2026-deepening] — cited by: clinical-trials-landscape.md, patient-experience-and-advocacy.md
Tomic D, et al. The epidemiology of type 1 diabetes mellitus in older adults. Nat Rev Endocrinol. 2025;21:92-104. PMID 39448829 — tags: [2026-deepening] — cited by: epidemiology-and-burden.md
Lin YK, et al. Characterising impaired awareness and associated risks through HypoA-Q. Diabetologia. 2025;68:433-443. PMID 39477881 — tags: [2026-deepening] — cited by: hypoglycemia.md
Galderisi A, et al. Trajectory of beta cell function and insulin clearance in stage 2 type 1 diabetes. Diabetologia. 2025;68:646-661. PMID 39560746 — tags: [2026-deepening] — cited by: disease-modifying-immunotherapy.md, staging-and-natural-history.md
Carré A, et al. Interferon-α promotes HLA-B-restricted presentation of antigens in human pancreatic β-cells. Nat Commun. 2025;16:765. PMID 39824805 — tags: [2026-deepening] — cited by: immunopathogenesis.md
Tauschmann M, et al. ISPAD 2024 Diabetes Technologies: Glucose Monitoring. Horm Res Paediatr. 2024;97:615-635. PMID 39884260 — tags: [2026-deepening] — cited by: guidelines.md
Howard V, et al. Nocturnal caregiving for juveniles with T1D. Psychol Health Med. 2025;30:1701-1722. PMID 40009726 — tags: [2026-deepening] — cited by: patient-experience-and-advocacy.md, psychosocial-and-behavioral.md
Sims EK, et al. IA-2A positivity increases risk of progression within and across established stages of type 1 diabetes. Diabetologia. 2025;68:993-1004. PMID 40016443 — tags: [2026-deepening] — cited by: overview.md, screening-and-early-detection.md, staging-and-natural-history.md
van Tienhoven R, et al. Genetic protection from type 1 diabetes resulting from accelerated insulin mRNA decay. Cell. 2025;188:2407-2416.e9. PMID 40112799 — tags: [2026-deepening] — cited by: immunopathogenesis.md
Zafra-Tanaka JH, et al. Patient relevant outcomes for type 1 diabetes management: a qualitative evidence synthesis. Diabet Med. 2025;42:e70016. PMID 40114395 — tags: [2026-deepening] — cited by: patient-experience-and-advocacy.md
Hering BJ, et al. Advances in Cell Replacement Therapies for Diabetes. Diabetes. 2025;74:1068-1077. PMID 40272266 — tags: [2026-deepening] — cited by: beta-cell-replacement.md
So M, et al. β-Cell Function Derived From Routine Measures Predicts Immunotherapy Response. Diabetes Care. 2025;48:1370-1376. PMID 40424079 — tags: [2026-deepening] — cited by: clinical-trials-landscape.md, disease-modifying-immunotherapy.md
Martinenghi S, et al. Prevention of diabetic ketoacidosis in relatives screened and followed in TrialNet. Diabetologia. 2025;68:1889-1898. PMID 40439773 — tags: [2026-deepening] — cited by: screening-and-early-detection.md, staging-and-natural-history.md
Wang R, et al. Stigma experienced by adolescents with T1D: systematic review and meta-synthesis. Diabet Med. 2025;42:e70088. PMID 40515441 — tags: [2026-deepening] — cited by: patient-experience-and-advocacy.md, psychosocial-and-behavioral.md
Rewers M. Health economic considerations of screening for early type 1 diabetes. Diabetes Obes Metab. 2025;27 Suppl 6:69-77. PMID 40555704 — tags: [2026-deepening] — cited by: screening-and-early-detection.md
Thabit H, et al. Fully closed-loop control with ultra-rapid versus standard insulin lispro. Diabet Med. 2025;42:e70122. PMID 40815068 — tags: [2026-deepening] — cited by: insulin-therapy-and-technology.md
Ades R, et al. What does qualitative evidence tell us about how having a diagnosis of type 1 diabetes mellitus impacts an individual's identity? J Health Psychol. 2026;31:983-1000. PMID 40875389 — tags: [2026-deepening] — cited by: patient-experience-and-advocacy.md
de Visser HS, et al. Automated Insulin Delivery Systems in Children and Adolescents: systematic review and meta-analysis. JAMA Pediatr. 2025;179:1162-1171. PMID 40920375 — tags: [2026-deepening] — cited by: insulin-therapy-and-technology.md
Donovan LE, et al. Closed-Loop Insulin Delivery in Type 1 Diabetes in Pregnancy. JAMA. 2025;334:2176-2185. PMID 41134589 — tags: [2026-deepening] — cited by: complications.md, insulin-therapy-and-technology.md, red-flags-and-safety-concerns.md
Kuusela S, et al. Islet autoimmunity and progression to type 1 diabetes in the Finnish DIPP study. Diabetologia. 2026;69:93-102. PMID 41204978 — tags: [2026-deepening] — cited by: staging-and-natural-history.md
Galderisi A, et al. Baseline Insulin Secretion Determines Response to Abatacept in Stage 1 Type 1 Diabetes. Diabetes. 2026;75:229-240. PMID 41237315 — tags: [2026-deepening] — cited by: biomarkers.md, clinical-trials-landscape.md, disease-modifying-immunotherapy.md
Biswas S, et al. Immunomodulatory interventions in type 1 diabetes: systematic review and meta-analysis. BMC Endocr Disord. 2025;25:270. PMID 41267047 — tags: [2026-deepening] — cited by: disease-modifying-immunotherapy.md
Chen W, et al. Economic evaluation of potential national childhood screening strategies for type 1 diabetes in Australia. Lancet Reg Health West Pac. 2025;65:101755. PMID 41362419 — tags: [2026-deepening] — cited by: screening-and-early-detection.md
Sebastian-Valles F, et al. Connected smart pen cap in adults with type 1 diabetes: randomized trial. Diabetologia. 2026;69:1191-1204. PMID 41634174 — tags: [2026-deepening] — cited by: insulin-therapy-and-technology.md
Sherr JL, et al. Persistent Burden of Severe Hypoglycemia and Impaired Awareness Despite Technology Use. Diabetes Care. 2026;49:650-657. PMID 41747141 — tags: [2026-deepening] — cited by: hypoglycemia.md
Sklar J, et al. Barriers to type 1 diabetes medication access and social media support. Diabet Med. 2026;43:e70313. PMID 41996632 — tags: [2026-deepening] — cited by: insulin-therapy-and-technology.md, patient-experience-and-advocacy.md
Templeman EL, et al. Accounting for Age-Related Increases in HbA1c Quantifies Progression Risk in Adults. Diabetes Care. 2026;49:1262-1269. PMID 42090204 — tags: [2026-deepening] — cited by: screening-and-early-detection.md, staging-and-natural-history.md
Delaney PWJ, et al. Reduced Prevalence of Impaired Awareness Over Two Decades in Youth. Diabetes Care. 2026;49:1280-1284. PMID 42138725 — tags: [2026-deepening] — cited by: hypoglycemia.md
Everett EM, et al. Contemporary Diabetes Technology and the Patient Experience. JAMA Netw Open. 2026;9:e2624260. PMID 42479430 — tags: [2026-deepening] — cited by: patient-experience-and-advocacy.md
Chauhan R, et al. Epidemiological and clinical insights from Type 1 Diabetes Global Registries. Diabetes Metab Syndr. 2026;20:103455. PMID 42551241 — tags: [2026-deepening] — cited by: complications.md, epidemiology-and-burden.md, overview.md
Piñar-Gutiérrez A, et al. Natural History of Mild Non-Proliferative Retinopathy Under Contemporary Care. Diabetes Technol Ther. 2026. PMID 42626886 — tags: [2026-deepening] — cited by: complications.md
Hassanein A, et al. Gene-edited hypoimmune islets as a cure for type 1 diabetes. Expert Opin Biol Ther. 2026. PMID 42626948 — tags: [2026-deepening] — cited by: beta-cell-replacement.md
Bellini MI, et al. Simultaneous Pancreas-Kidney Versus Kidney Transplantation Alone. Med Sci (Basel). 2026;14. PMID 42646588 — tags: [2026-deepening] — cited by: beta-cell-replacement.md